{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:26:54Z","timestamp":1790908014999,"version":"4.1.0"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2013,1,22]],"date-time":"2013-01-22T00:00:00Z","timestamp":1358812800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0054506","type":"journal-article","created":{"date-parts":[[2013,1,22]],"date-time":"2013-01-22T22:52:42Z","timestamp":1358895162000},"page":"e54506","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["MicroRNA-Mediated Suppression of Oncolytic Adenovirus Replication in Human Liver"],"prefix":"10.1371","volume":"8","author":[{"given":"Erkko","family":"Yl\u00f6sm\u00e4ki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Lavilla-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sari","family":"J\u00e4\u00e4maa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"V\u00e4h\u00e4-Koskela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taija","family":"af H\u00e4llstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akseli","family":"Hemminki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Arola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heikki","family":"M\u00e4kisalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalle","family":"Saksela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,1,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"DP Bartel","year":"2004","journal-title":"Cell"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"D154","DOI":"10.1093\/nar\/gkm952","article-title":"miRBase: tools for microRNA genomics","volume":"36","author":"S Griffiths-Jones","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"DP Bartel","year":"2009","journal-title":"Cell"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.cell.2012.04.005","article-title":"Roles for microRNAs in conferring robustness to biological processes","volume":"149","author":"MS Ebert","year":"2012","journal-title":"Cell"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"GA Calin","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/dna.2006.0554","article-title":"miRNA profiling for diagnosis and prognosis of human cancer","volume":"26","author":"C Jay","year":"2007","journal-title":"DNA Cell Biol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/dna.2006.0555","article-title":"Unique MicroRNA signature and clinical outcome of cancers","volume":"26","author":"SL Yu","year":"2007","journal-title":"DNA Cell Biol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.bbagrm.2008.05.005","article-title":"The roles of microRNAs in mammalian virus infection","volume":"1779","author":"R Grassmann","year":"2008","journal-title":"Biochimica et biophysica acta"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.febslet.2011.07.015","article-title":"Antiviral effects of human microRNAs and conservation of their target sites","volume":"585","author":"A Russo","year":"2011","journal-title":"FEBS letters"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1101\/gad.17352611","article-title":"Viruses and microRNAs: RISCy interactions with serious consequences","volume":"25","author":"BR Cullen","year":"2011","journal-title":"Genes Dev"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/mt.2008.288","article-title":"MicroRNAs and the regulation of vector tropism","volume":"17","author":"EJ Kelly","year":"2009","journal-title":"Mol Ther"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.chom.2008.08.003","article-title":"Harnessing endogenous miRNAs to control virus tissue tropism as a strategy for developing attenuated virus vaccines","volume":"4","author":"D Barnes","year":"2008","journal-title":"Cell Host Microbe"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/nm.1776","article-title":"Engineering microRNA responsiveness to decrease virus pathogenicity","volume":"14","author":"EJ Kelly","year":"2008","journal-title":"Nat Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1021\/mp100219n","article-title":"Oncolytic adenoviruses for the treatment of human cancer: focus on translational and clinical data","volume":"8","author":"S Pesonen","year":"2011","journal-title":"Mol Pharm"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nbt.2287","article-title":"Oncolytic virotherapy","volume":"30","author":"SJ Russell","year":"2012","journal-title":"Nat Biotechnol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/mt.2009.266","article-title":"Current issues and future directions of oncolytic adenoviruses","volume":"18","author":"M Yamamoto","year":"2010","journal-title":"Mol Ther"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2174\/156652307780859062","article-title":"Current advances and future challenges in Adenoviral vector biology and targeting","volume":"7","author":"SK Campos","year":"2007","journal-title":"Curr Gene Ther"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.addr.2009.03.013","article-title":"Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis","volume":"61","author":"DE Dorer","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1172\/JCI9762","article-title":"Replication-selective adenoviruses as oncolytic agents","volume":"105","author":"C Heise","year":"2000","journal-title":"J Clin Invest"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1089\/hum.1997.8.10-1195","article-title":"Liver-directed gene transfer in non-human primates","volume":"8","author":"DE Sullivan","year":"1997","journal-title":"Hum Gene Ther"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1099\/0022-1317-40-1-45","article-title":"Infection of mouse liver by human adenovirus type 5","volume":"40","author":"SJ Duncan","year":"1978","journal-title":"J Gen Virol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"11009","DOI":"10.1128\/JVI.01608-08","article-title":"Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific MicroRNA","volume":"82","author":"E Yl\u00f6sm\u00e4ki","year":"2008","journal-title":"J Virol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e1000440","DOI":"10.1371\/journal.ppat.1000440","article-title":"Use of tissue-specific microRNA to control pathology of wild-type adenovirus without attenuation of its ability to kill cancer cells","volume":"5","author":"R Cawood","year":"2009","journal-title":"PLoS Pathog"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e16152","DOI":"10.1371\/journal.pone.0016152","article-title":"MicroRNA controlled adenovirus mediates anti-cancer efficacy without affecting endogenous microRNA activity","volume":"6","author":"R Cawood","year":"2011","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e8916","DOI":"10.1371\/journal.pone.0008916","article-title":"Double-detargeted oncolytic adenovirus shows replication arrest in liver cells and retains neuroendocrine cell killing ability","volume":"5","author":"J Leja","year":"2010","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/sj.gt.3301515","article-title":"CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors","volume":"8","author":"R Alemany","year":"2001","journal-title":"Gene Ther"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4161\/rna.1.2.1066","article-title":"miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1","volume":"1","author":"J Chang","year":"2004","journal-title":"RNA Biol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0887-2333(99)00047-8","article-title":"Organ slices as an in vitro test system for drug metabolism in human liver, lung and kidney","volume":"13","author":"R De Kanter","year":"1999","journal-title":"Toxicol In Vitro"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1056-8719(97)00060-9","article-title":"Comparison of five incubation systems for rat liver slices using functional and viability parameters","volume":"38","author":"P Olinga","year":"1997","journal-title":"J Pharmacol Toxicol Methods"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1128\/JVI.80.7.3549-3558.2006","article-title":"Replication properties of human adenovirus in vivo and in cultures of primary cells from different animal species","volume":"80","author":"C Jogler","year":"2006","journal-title":"Journal of virology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1089\/10430340150218369","article-title":"E1B-deleted adenovirus (dl1520) gene therapy for patients with primary and secondary liver tumors","volume":"12","author":"NA Habib","year":"2001","journal-title":"Hum Gene Ther"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1200\/JCO.2003.09.114","article-title":"Phase II trial of intravenous CI-1042 in patients with metastatic colorectal cancer","volume":"21","year":"2003","journal-title":"J Clin Oncol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"7673","DOI":"10.1038\/sj.onc.1209040","article-title":"Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus","volume":"24","author":"AJ Berk","year":"2005","journal-title":"Oncogene"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1101\/gad.813200","article-title":"The Rb\/E2F pathway: expanding roles and emerging paradigms","volume":"14","author":"JW Harbour","year":"2000","journal-title":"Genes Dev"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0042-6822(90)90134-D","article-title":"Adenovirus E1A under the control of heterologous promoters: wide variation in E1A expression levels has little effect on virus replication","volume":"179","author":"MM Hitt","year":"1990","journal-title":"Virology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/0014-4827(89)90058-X","article-title":"H-ras gene is expressed at the G1 phase in primary cultures of hepatocytes","volume":"185","author":"T Ikeda","year":"1989","journal-title":"Exp Cell Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"11484","DOI":"10.1074\/jbc.271.19.11484","article-title":"Growth factor dependence of progression through G1 and S phases of adult rat hepatocytes in vitro. Evidence of a mitogen restriction point in mid-late G1","volume":"271","author":"P Loyer","year":"1996","journal-title":"J Biol Chem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0960-9822(02)00809-6","article-title":"Identification of tissue-specific microRNAs from mouse","volume":"12","author":"M Lagos-Quintana","year":"2002","journal-title":"Curr Biol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.cell.2007.04.040","article-title":"A mammalian microRNA expression atlas based on small RNA library sequencing","volume":"129","author":"P Landgraf","year":"2007","journal-title":"Cell"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1471-2164-8-166","article-title":"Characterization of microRNA expression profiles in normal human tissues","volume":"8","author":"Y Liang","year":"2007","journal-title":"BMC Genomics"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nmeth704","article-title":"A custom microarray platform for analysis of microRNA gene expression","volume":"1","author":"JM Thomson","year":"2004","journal-title":"Nat Methods"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.1178178","article-title":"Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection","volume":"327","author":"RE Lanford","year":"2010","journal-title":"Science"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood-2009-03-208835","article-title":"Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer","volume":"114","author":"R Alba","year":"2009","journal-title":"Blood"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2008.01.016","article-title":"Adenovirus serotype 5 hexon mediates liver gene transfer","volume":"132","author":"SN Waddington","year":"2008","journal-title":"Cell"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"32015","DOI":"10.1074\/jbc.M109.016774","article-title":"MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib","volume":"284","author":"S Bai","year":"2009","journal-title":"J Biol Chem"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/hep.22806","article-title":"MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma","volume":"49","author":"WC Tsai","year":"2009","journal-title":"Hepatology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1038\/onc.2009.211","article-title":"Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties","volume":"28","author":"C Coulouarn","year":"2009","journal-title":"Oncogene"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcb.20982","article-title":"Downregulation of miR-122 in the rodent and human hepatocellular carcinomas","volume":"99","author":"H Kutay","year":"2006","journal-title":"J Cell Biochem"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/cgt.2009.3","article-title":"Armed replicating adenoviruses for cancer virotherapy","volume":"16","author":"JJ Cody","year":"2009","journal-title":"Cancer Gene Ther"},{"key":"ref50","first-page":"3858","article-title":"Growth of human hepatoma cells lines with differentiated functions in chemically defined medium","volume":"42","author":"H Nakabayashi","year":"1982","journal-title":"Cancer Res"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/sj.onc.1203251","article-title":"A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo","volume":"19","author":"J Fueyo","year":"2000","journal-title":"Oncogene"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Hamilton MA, Russo RC, Thurston RV (1977) Trimmed Spearman-K\u00e4rber method for estimating median lethal concentrations in toxicity bioassays. Environ Sci Technol 11.","DOI":"10.1021\/es60130a004"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jso.2930310402","article-title":"Tumor measurement in the nude mouse","volume":"31","author":"DM Euhus","year":"1986","journal-title":"J Surg Oncol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF00300234","article-title":"Determination of subcutaneous tumor size in athymic (nude) mice","volume":"24","author":"MM Tomayko","year":"1989","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0054506","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T12:13:15Z","timestamp":1589026395000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0054506"}},"subtitle":[],"editor":[{"given":"KT.","family":"Jeang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,1,22]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,1,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0054506","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,22]]}}}